Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | DRD2 | P14416 | 2/20 | 0.50 |
| ▸ | DRD3 | P35462 | 2/20 | 0.50 |
| ▸ | HTR2B | P41595 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.50 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | FLT1 | P17948 | 1/20 | 0.47 |
| ▸ | FLT4 | P35916 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2348770 | 1.00 | GAA (0.51) | GAAMEN1KMT2ADRD2DRD3 | |
| SCHEMBL10744283 | 0.88 | POLB (0.46) | GAADRD2DRD3HTR2BKCNH2 | |
| SCHEMBL8544664 | 0.86 | MAPK1 (0.56) | GAADRD2DRD3HTR2BKCNH2 | |
| SCHEMBL21054952 | 0.85 | GAA (0.56) | GAAMEN1KMT2ADRD2DRD3 | |
| SCHEMBL10744279 | 0.84 | GAA (0.51) | GAAMEN1KMT2ADRD2DRD3 | |
| SCHEMBL27631394 | 0.84 | GAA (0.55) | GAAMEN1KMT2ADRD2DRD3 | |
| SCHEMBL10723820 | 0.84 | DRD2 (0.50) | GAADRD2DRD3HTR2BKCNH2 | |
| SCHEMBL31038303 | 0.84 | CA2 (0.52) | GAAMEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL30219287 | 0.84 | SMN1; SMN2 (0.57) | GAAMEN1KMT2ADRD2DRD3 | |
| SCHEMBL29598834 | 0.84 | GAA (0.65) | GAAMEN1KMT2ADRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114436927-B | Amisulpride derivative, homogeneous enzyme immunoassay reagent and preparation method | 合肥爱索特克医学检验实验室有限公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-113735755-B | Preparation method of amisulpride | 深圳市新浩瑞医药科技有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-116836093-A | 4-amino-5-alkylsulfinyl-2-methoxybenzoic acid compound and preparation method and application thereof | 江苏恩华药业股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116621752-A | Preparation method of amisulpride impurity B | 广州隽沐生物科技股份有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-115300471-B | Orally disintegrating amisulpride tablet and preparation method thereof | 则正(济南)生物科技有限公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-115300471-A | Orally disintegrating amisulpride tablet and preparation method thereof | 则正(济南)生物科技有限公司 | 2022-11-08 | — | — | CN | disclosed |
| US-20220323409-A1 | MODIFIED RELEASE FORMULATIONS AND USES THEREOF | SUNOVION PHARMACEUTICALS INC. | 2022-10-13 | — | — | US | disclosed |
| CN-114507174-A | Synthesis method of amisulpride impurity H | 浙江华海药业股份有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-114436927-A | Amisulpride derivative, homogeneous enzyme immunoassay reagent and preparation method | 安徽爱索特克医学检验实验室有限公司 | 2022-05-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220323409-A1 | MODIFIED RELEASE FORMULATIONS AND USES THEREOF | RYR2, ABCG2, ATP2A3 | GAA 476/4885MEN1 2905/4885KMT2A 4777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.